Income Statement Presentation 2023

2022: Diagnostics Division Core operating profit decline of -5% Roche 2022 CHFm % sales 2022 vs. 2021 CER growth Sales 17,730 100.0 3% Royalties & other op. inc. 68 0.4 -13% Cost of sales -8,813 -49.7 4% M & D -2,889 -16.3 1% R & D -1,957 -11.0 12% G&A -583 -3.3 10% Admin +4% Core operating profit 3,556 20.1 -5% -9% in CHF CER=Constant Exchange Rates 41 44

View entire presentation